NB 001 may reduce symptom duration in patients with herpes labialis

Source: Inpharma, Volume 1, Number 1498, 2005-07-30 , pp. 7-7(1)

Publisher: Adis International

Keywords: Drug-delivery-systems; Herpes-labialis, treatment; NB-001, therapeutic use; Research-and-development; Trial-result-clinical

Document Type: Short communication

Links for this article